Tumor necrosis factor receptor 1 signaling complex I (TNFR1-SC I)

Tumor necrosis factor receptor 1 (TNFR1) signaling complex I is a transient, membrane-bound multi-protein assembly formed immediately upon the binding of Tumor Necrosis Factor-alpha (TNF-α) to its receptor, TNFR1 [1.1.2, 1.3.1]. This complex serves as the primary platform for initiating pro-inflammatory and pro-survival signaling pathways, most notably the activation of Nuclear Factor-kappa B (NF-κB) and Mitogen-Activated Protein Kinases (MAPKs) like JNK and p38 [1.3.2, 1.3.4]. Key components of Complex I include the adaptor protein TRADD, the kinase RIPK1, ubiquitin ligases TRAF2/5 and cIAP1/2, and the Linear Ubiquitin Chain Assembly Complex (LUBAC) [1.3.1, 1.3.3]. The stability of Complex I is critical for cell survival; its destabilization or the inhibition of its components can trigger a transition to cytosolic pro-apoptotic (Complex IIa/b) or pro-necroptotic (Complex IIc/necrosome) complexes [1.1.1, 1.3.2]. Dysregulation of this complex is central to the pathogenesis of various inflammatory and autoimmune disorders, such as rheumatoid arthritis and inflammatory bowel disease, as well as certain cancers and neurodegenerative conditions [1.2.1, 1.2.5]. Therapeutic strategies targeting this complex include broad TNF-α inhibitors, TNFR1-specific antagonists, and small molecules targeting specific components like RIPK1 or IAPs to modulate the balance between inflammation and cell death [1.2.2, 1.2.5].

Other names

Complex ITNF-RSC Complex IMembrane-bound TNFR1 complexPrimary TNFR1 signaling complex

Formation of a membrane-bound signaling scaffold that recruits E3 ubiquitin ligases and kinases to activate NF-κB and MAPK pathways, promoting pro-inflammatory gene expression and cell survival.